MAIA AMEX
MAIA Biotechnology, Inc.
1W: -6.1%
1M: -12.8%
3M: -40.9%
YTD: -23.1%
1Y: -31.7%
3Y: -50.6%
$1.23
-0.03 (-2.38%)
Weekly Expected Move ±8.3%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$0.7M
Congress—
ETF Holdings—
Key Statistics
Market Cap$47.6M
52W Range0.87-3.19
Volume556,566
Avg Volume881,975
Beta0.23
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOVlad Vitoc
Employees13
SectorHealthcare
IndustryBiotechnology
IPO Date2022-07-28
WebsiteMAIABiotech.com
444 West Lake Street
Chicago, IL 60606
US
Chicago, IL 60606
US
312 416 8592
About MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.
Latest News
MAIA Biotechnology expects $33M capital raise to fund Phase 3 trial of anticancer therapy
Crude Oil Surges Over 6%; Target Profit Tops Views
12 Health Care Stocks Moving In Tuesday's Intraday Session
Dow Dips 900 Points; Best Buy Posts Upbeat Earnings
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Vitoc Vlad | A-Award | 800,000 | $1.28 | 2026-04-10 |
| Gryaznov Sergei | A-Award | 400,000 | $1.28 | 2026-04-10 |
| Himmelreich Jeffrey | A-Award | 30,000 | $1.28 | 2026-04-10 |
| CHAOUKI STEVEN M | A-Award | 27,907 | $1.40 | 2026-03-31 |
| Guerrero Ramiro | A-Award | 27,258 | $1.40 | 2026-03-31 |